301 related articles for article (PubMed ID: 18302675)
1. Cellular basis of verruciform xanthoma: immunohistochemical and ultrastructural characterization.
Ide F; Obara K; Yamada H; Mishima K; Saito I; Kusama K
Oral Dis; 2008 Mar; 14(2):150-7. PubMed ID: 18302675
[TBL] [Abstract][Full Text] [Related]
2. Verruciform xanthoma: immunohistochemical characterization of xanthoma cell phenotypes.
Rawal SY; Kalmar JR; Tatakis DN
J Periodontol; 2007 Mar; 78(3):504-9. PubMed ID: 17335374
[TBL] [Abstract][Full Text] [Related]
3. Verruciform xanthoma of the oral cavity: clinicopathological study relating to pathogenesis. Report of three cases.
Hu JA; Li Y; Li S
APMIS; 2005 Sep; 113(9):629-34. PubMed ID: 16218939
[TBL] [Abstract][Full Text] [Related]
4. [Verruciform xanthoma].
Rhinow K; Kalz S; Gelderblom R; Reichart A
Mund Kiefer Gesichtschir; 2003 Jan; 7(1):52-5. PubMed ID: 12556987
[TBL] [Abstract][Full Text] [Related]
5. [Pathomorphological and immunohistochemical study of verruciform xanthoma].
Ben CR
Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Jan; 29(1):47-9. PubMed ID: 7995137
[No Abstract] [Full Text] [Related]
6. Verruciform xanthoma and concomitant lichen planus of the oral mucosa. A report of three cases.
Polonowita AD; Firth NA; Rich AM
Int J Oral Maxillofac Surg; 1999 Feb; 28(1):62-6. PubMed ID: 10065655
[TBL] [Abstract][Full Text] [Related]
7. Characterization of verruciform xanthoma by in situ hybridization and immunohistochemistry.
Iamaroon A; Vickers RA
J Oral Pathol Med; 1996 Aug; 25(7):395-400. PubMed ID: 8890055
[TBL] [Abstract][Full Text] [Related]
8. Verruciform xanthoma of the oral mucosa. Report of four cases and a review of the literature.
Oliveira PT; Jaeger RG; Cabral LA; Carvalho YR; Costa AL; Jaeger MM
Oral Oncol; 2001 Apr; 37(3):326-31. PubMed ID: 11287290
[TBL] [Abstract][Full Text] [Related]
9. Contribution of xanthoma tissue-derived LDL density substances in the transformation of macrophages to foam cells.
Ikeda M; Nakajima K; Nakajima H; Matsumoto M; Seike M; Kodama H
J Dermatol Sci; 2006 Dec; 44(3):161-8. PubMed ID: 17092695
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.
Takahashi K; Takeya M; Sakashita N
Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354
[TBL] [Abstract][Full Text] [Related]
11. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan forms complexes with low density lipoprotein while also inducing foam cell infiltration in the dermis.
Seike M; Ikeda M; Matsumoto M; Hamada R; Takeya M; Kodama H
J Dermatol Sci; 2006 Mar; 41(3):197-204. PubMed ID: 16356687
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of protein kinase Cbeta prevents foam cell formation by reducing scavenger receptor A expression in human macrophages.
Osto E; Kouroedov A; Mocharla P; Akhmedov A; Besler C; Rohrer L; von Eckardstein A; Iliceto S; Volpe M; Lüscher TF; Cosentino F
Circulation; 2008 Nov; 118(21):2174-82. PubMed ID: 18981301
[TBL] [Abstract][Full Text] [Related]
14. Verruciform xanthoma of the oral mucosa: an immunohistochemical and ultrastructural study of two cases.
Shin HI; Choi KS; Nagatsuka H; Murata M; Nagai N
Oral Oncol; 1997 Jul; 33(4):279-83. PubMed ID: 9307719
[TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis.
Aslanian AM; Charo IF
Circulation; 2006 Aug; 114(6):583-90. PubMed ID: 16880330
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
Sawada S; Harada K; Isse K; Sato Y; Sasaki M; Kaizaki Y; Nakanuma Y
Pathol Int; 2007 Oct; 57(10):652-63. PubMed ID: 17803654
[TBL] [Abstract][Full Text] [Related]
17. Verruciform xanthoma of the oral mucosa. Report of five cases and review of the literature.
Buchner A; Hansen LS; Merrell PW
Arch Dermatol; 1981 Sep; 117(9):563-5. PubMed ID: 7294847
[TBL] [Abstract][Full Text] [Related]
18. [Study of the clinicopathology on verruciform xanthoma of the oral cavity].
Hu JA; Li YN; Li SY; Ying H
Shanghai Kou Qiang Yi Xue; 2005 Aug; 14(4):370-3. PubMed ID: 16155700
[TBL] [Abstract][Full Text] [Related]
19. Oral and maxillofacial pathology case of the month. Verruciform xanthoma.
Cheng YS; Wright J; Lucente J; McQuade MJ
Tex Dent J; 2010 Jan; 127(1):126-7, 130-1. PubMed ID: 20162945
[No Abstract] [Full Text] [Related]
20. Verruciform xanthoma of the oral mucosa: a clinicopathological study with immunohistochemical findings relating to pathogenesis.
Mostafa KA; Takata T; Ogawa I; Ijuhin N; Nikai H
Virchows Arch A Pathol Anat Histopathol; 1993; 423(4):243-8. PubMed ID: 8236821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]